Various countries have implemented regulatory measures to manage the risk of endocrine disruptors. For example, the European Union's REACH regulation requires companies to identify and manage the risks linked with the substances they manufacture and market in the EU. The United States Environmental Protection Agency (EPA) also has programs dedicated to evaluating the potential endocrine-disrupting effects of chemicals.
